Literature DB >> 15769672

Dynamics of cellular NO-cGMP signaling.

John Garthwaite1.   

Abstract

Despite its widespread biological importance, knowledge about the basic workings of the nitric oxide (NO) signaling pathway at the cellular level has been unsatisfactory. As reviewed here, recent findings have begun to rectify this deficiency. Elementary NO signals may be very discrete, being short lived (seconds or less), of low amplitude (peak concentration in the low nanomolar range), and confined to the immediate vicinity of the source (a micron or less). A more global signal may occur when many nearby sources are active simultaneously, though the amplitude appears to remain low. The properties of guanylyl cyclase (GC)-coupled NO receptors, for which a kinetic model is introduced, are well tuned to detect NO signals. The receptors can respond even to brief pulses of NO because they activate and deactivate with sub-second kinetics and they possess the appropriate sensitivity to low nanomolar NO concentrations. In some cells at least, the NO-evoked GC activity is very high, equivalent to the synthesis of up to 100 microM cGMP per second. The resulting shapes and sizes of cellular cGMP responses can vary considerably from cell to cell, however, which is likely to have repercussions for the selection of downstream pathways. The cellular diversity can be explained by variations in the rates at which the receptors desensitize and in the rates of cGMP hydrolysis by phosphodiesterases. There is a growing list of factors that may serve to modulate NO receptor function in cells, including Ca2+, ATP, phosphorylation by kinases, and physical interactions with other proteins.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15769672     DOI: 10.2741/1666

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  15 in total

1.  Inactivation of nitric oxide by rat cerebellar slices.

Authors:  C N Hall; J Garthwaite
Journal:  J Physiol       Date:  2006-09-14       Impact factor: 5.182

2.  Nitric oxide activation of guanylyl cyclase in cells revisited.

Authors:  Brijesh Roy; John Garthwaite
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-01       Impact factor: 11.205

3.  Probing the presence of the ligand-binding haem in cellular nitric oxide receptors.

Authors:  B Roy; E Mo; J Vernon; J Garthwaite
Journal:  Br J Pharmacol       Date:  2008-01-21       Impact factor: 8.739

Review 4.  New insight into the functioning of nitric oxide-receptive guanylyl cyclase: physiological and pharmacological implications.

Authors:  John Garthwaite
Journal:  Mol Cell Biochem       Date:  2009-12-11       Impact factor: 3.396

5.  Gating of long-term depression by Ca2+/calmodulin-dependent protein kinase II through enhanced cGMP signalling in cerebellar Purkinje cells.

Authors:  Shin-ya Kawaguchi; Tomoo Hirano
Journal:  J Physiol       Date:  2013-01-07       Impact factor: 5.182

Review 6.  Role of nitric oxide in cerebellar development and function: focus on granule neurons.

Authors:  Antonio Contestabile
Journal:  Cerebellum       Date:  2012-03       Impact factor: 3.847

Review 7.  Parallel evolution of nitric oxide signaling: diversity of synthesis and memory pathways.

Authors:  Leonid L Moroz; Andrea B Kohn
Journal:  Front Biosci (Landmark Ed)       Date:  2011-06-01

8.  Differential patterning of cGMP in vascular smooth muscle cells revealed by single GFP-linked biosensors.

Authors:  Lydia W M Nausch; Jonathan Ledoux; Adrian D Bonev; Mark T Nelson; Wolfgang R Dostmann
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-28       Impact factor: 11.205

9.  Sub-Nanomolar Sensitivity of Nitric Oxide Mediated Regulation of cGMP and Vasomotor Reactivity in Vascular Smooth Muscle.

Authors:  Kara F Held; Wolfgang R Dostmann
Journal:  Front Pharmacol       Date:  2012-07-12       Impact factor: 5.810

10.  Mechanisms of activity-dependent plasticity in cellular nitric oxide-cGMP signaling.

Authors:  Edward J Halvey; Jeffrey Vernon; Brijesh Roy; John Garthwaite
Journal:  J Biol Chem       Date:  2009-07-15       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.